About Synapse Medicine
Synapse Medicine is a company based in Bordeaux (France) founded in 2017.. Synapse Medicine has raised $38.81 million across 3 funding rounds from investors including BNP Paribas, Bpifrance and Korelya Capital. Synapse Medicine offers products and services including Drug Information Monographs, Patient Clinical Profile, Allergy Search, Drug Interactions Analysis, and Order Entry. Synapse Medicine operates in a competitive market with competitors including Wellth, Kinsa, Cureatr, Phil and Capsa Healthcare, among others.
- Headquarter Bordeaux, France
-
Sectors
TechnologyHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$38.81 M (USD)
in 3 rounds
-
Latest Funding Round
$27.98 M (USD), Series B
Mar 01, 2022
-
Investors
BNP Paribas
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Synapse Medicine
Synapse Medicine offers a comprehensive portfolio of products and services, including Drug Information Monographs, Patient Clinical Profile, Allergy Search, Drug Interactions Analysis, and Order Entry. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides medication suggestions as user types.
Enables personalized prescriptions based on clinical conditions.
Allows quick input of drug allergies through autocomplete.
Detects interactions and contraindications for safer prescribing.
Facilitates entering dosing specifics for medications.
Unlock access to complete
Funding Insights of Synapse Medicine
Synapse Medicine has successfully raised a total of $38.81M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $27.98 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $28.0M
-
First Round
First Round
(19 Mar 2019)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Series B - Synapse Medicine | Valuation | Korelya Capital | |
| Jul, 2020 | Amount | Series A - Synapse Medicine | Valuation | MACSF | |
| Mar, 2019 | Amount | Seed - Synapse Medicine | Valuation | XAnge |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Synapse Medicine
Synapse Medicine has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include BNP Paribas, Bpifrance and Korelya Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on investing in tech startups
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on tech companies
|
Founded Year | Domain | Location | |
|
Venture capital is provided to French companies by the firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Synapse Medicine
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Synapse Medicine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Synapse Medicine Comparisons
Competitors of Synapse Medicine
Synapse Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wellth, Kinsa, Cureatr, Phil and Capsa Healthcare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provides AI and cloud-based platform for doctors for patient engagement and care
|
|
| domain | founded_year | HQ Location |
Thermometers and mobile apps are provided for tracking fever symptoms.
|
|
| domain | founded_year | HQ Location |
Cloud-based medication management software is provided for healthcare providers.
|
|
| domain | founded_year | HQ Location |
Prescription drugs refill management solutions
|
|
| domain | founded_year | HQ Location |
Medication management systems are supplied to healthcare providers and pharmacies.
|
|
| domain | founded_year | HQ Location |
Medication management is specialized for chronic disease patients.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Synapse Medicine
Frequently Asked Questions about Synapse Medicine
When was Synapse Medicine founded?
Synapse Medicine was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is Synapse Medicine located?
Synapse Medicine is headquartered in Bordeaux, France.
Who is the current CEO of Synapse Medicine?
Clement Goehrs is the current CEO of Synapse Medicine.
Is Synapse Medicine a funded company?
Synapse Medicine is a funded company, having raised a total of $38.81M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.83M, raised on Mar 19, 2019.
What does Synapse Medicine do?
Synapse Medicine was founded in 2017 in Bordeaux, France, within the health technology sector. A virtual assistant for drug prescription is offered through the platform, along with information on medical errors. These resources are delivered to healthcare professionals, telemedicine companies, hospitals, and other facilities to support clinical decision-making and error prevention across operations.
Who are the top competitors of Synapse Medicine?
Synapse Medicine's top competitors include Wellth, Phil and Capsa Healthcare.
What products or services does Synapse Medicine offer?
Synapse Medicine offers Drug Information Monographs, Patient Clinical Profile, Allergy Search, Drug Interactions Analysis, and Order Entry.
Who are Synapse Medicine's investors?
Synapse Medicine has 8 investors. Key investors include BNP Paribas, Bpifrance, Korelya Capital, XAnge, and MACSF.